XASX
MCP
Market cap13mUSD
Oct 09, Last price
0.14AUD
1D
0.00%
1Q
-12.90%
Jan 2017
-86.89%
Name
McPherson's Ltd
Chart & performance
P/E
—
P/S
0.16
EPS
—
Div yield, %
14.81%
Shrs. gr., 5y
3.36%
Rev. gr., 5y
-10.01%
Revenues
118m
-14.88%
Net income
-20m
L+34.72%
CFO
675k
-69.47%
Dividend
Mar 04, 20240.02 AUD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
McPherson's Limited is a company dedicated to distributing a wide array of health, beauty, and personal care products across Australia, New Zealand, Asia, and international markets. Their extensive portfolio includes cosmetics, haircare solutions, skincare items, and general hygiene goods, such as facial cleansing wipes, cotton wool pads, and foot comfort accessories. Additionally, the firm supplies nutritional vitamins and supplements, along with essential kitchen items like baking parchment, food cling film, and aluminum foil. McPherson's primarily markets its merchandise under its own established brand portfolio, featuring popular names like Dr. LeWinn's, A'kin, Manicare, Lady Jayne, Swisspers, Multix, Fusion Health, Oriental Botanicals, Moosehead, and Maseur. This Australian-based enterprise, headquartered in Kingsgrove, boasts a long history, having been founded in 1860.
Key people
Chairman of the Board, Non-Executive Independent Director · since 2015
Paul Witheridge
Chief Financial Officer, Joint Company Secretary · since 2011
Paul John Maguire
Managing Director, Executive Director · since 2015
L. Pirozzi
International Sales Director · since 2018
Philip R. Bennett
Joint Company Secretary · since 2012
Non-Executive Independent Director · since 2015
Alison J. Mew
Non-Executive Independent Director · since 2018
Non-Executive Independent Director · since 2018
Grant William Peck
Non-Executive Independent Director · since 2017
Headquarters & legal address
105 Vanessa Street
KINGSGROVE, NSW 2208
AU
KINGSGROVE, NSW 2208
AU
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||